AVITA Medical, Inc. (AVH.XA)
| Previous close | 3.1500 |
| Open | 3.1000 |
| Bid | 3.0900 x N/A |
| Ask | 3.1500 x N/A |
| Day's range | 3.1000 - 3.1500 |
| 52-week range | 2.3400 - 5.6100 |
| Volume | |
| Avg. volume | 33,783 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3010 |
| Earnings date | 07 Nov 2024 - 11 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Top High Growth Tech Stocks To Watch In September 2024
The market is up 1.6% over the last week, with the Information Technology sector up 4.2%. In the last year, the market has climbed 22%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these optimistic trends can be crucial for investors looking to capitalize on future opportunities.
GlobeNewswireAVITA Medical to Present at 2024 Cantor Global Healthcare Conference
VALENCIA, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that David O’Toole, Chief Financial Officer, will present at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. Eastern Time. A live webcast of the presentation will be accessible under the Events & Presentations
- GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
VALENCIA, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that management will participate in Lake Street Capital Markets’ 8th Annual Best Ideas Growth (BIG8) Conference in New York on September 12, 2024. Jim Corbett, Chief Executive Officer, will host one-on-one meetings with institutional investors throughout
